Creotech Instruments S.A.

WSE:CRI Stock Report

Market Cap: zł2.4b

Creotech Instruments Future Growth

Future criteria checks 2/6

Creotech Instruments is forecast to grow revenue at 40.7% per annum. EPS is expected to grow by 56.2% per annum.

Key information

n/a

Earnings growth rate

56.17%

EPS growth rate

Aerospace & Defense earnings growth10.9%
Revenue growth rate40.7%
Future return on equityn/a
Analyst coverage

Low

Last updated07 Jul 2026

Recent future growth updates

No updates

Recent updates

New Narrative Jul 03

$CRI Creotech Instruments (WSE:CRI): Two Minute Drill

Poland’s sovereign satellite monopoly. €59M ESA contract, 40 sats/yr by 2029.
Analysis Article Jan 13

Investors Appear Satisfied With Creotech Instruments S.A.'s (WSE:CRI) Prospects As Shares Rocket 28%

The Creotech Instruments S.A. ( WSE:CRI ) share price has done very well over the last month, posting an excellent gain...
Analysis Article Sep 30

Revenues Tell The Story For Creotech Instruments S.A. (WSE:CRI) As Its Stock Soars 28%

Creotech Instruments S.A. ( WSE:CRI ) shareholders have had their patience rewarded with a 28% share price jump in the...
Analysis Article Jul 18

Here's Why We're Not Too Worried About Creotech Instruments' (WSE:CRI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analysis Article Oct 08

Creotech Instruments S.A.'s (WSE:CRI) Popularity With Investors Under Threat As Stock Sinks 25%

Unfortunately for some shareholders, the Creotech Instruments S.A. ( WSE:CRI ) share price has dived 25% in the last...
Analysis Article Feb 21

Is Creotech Instruments (WSE:CRI) In A Good Position To Invest In Growth?

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Earnings and Revenue Growth Forecasts

WSE:CRI - Analysts future estimates and past financials data (PLN Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028515N/AN/AN/A1
12/31/2027363N/AN/AN/A1
12/31/2026258N/AN/AN/A1
3/31/20261469-210N/A
12/31/2025150202250N/A
9/30/202588-5-1412N/A
6/30/202573-61338N/A
3/31/202533-12-28-1N/A
12/31/202420-18-38-19N/A
9/30/202434-20-2-2N/A
6/30/202441-1613N/A
3/31/202442-16-21N/A
12/31/202344-141515N/A
9/30/202344-12-714N/A
6/30/202338-10-116N/A
3/31/202336-9-76N/A
12/31/202234-7-19-7N/A
9/30/202234-5-24-14N/A
6/30/202233-2-18-10N/A
3/31/2022330-20-12N/A
12/31/2021330-20-11N/A
9/30/202129-1-15-4N/A
12/31/2020292-80N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CRI's forecast earnings growth is above the savings rate (5.3%).

Earnings vs Market: Insufficient data to determine if CRI's earnings are forecast to grow faster than the Polish market

High Growth Earnings: Insufficient data to determine if CRI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CRI's revenue (40.7% per year) is forecast to grow faster than the Polish market (4.6% per year).

High Growth Revenue: CRI's revenue (40.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CRI's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/10 05:59
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Creotech Instruments S.A. is covered by 0 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.